USC.edu
Are You a Patient?

Gustavo Jimenez-Maggiora

Assistant Professor Of Research Neurology

Image of Gustavo Jimenez-Maggiora
Is this your profile? Click to edit
Email [email protected]
CTSI Profile

Education and Training

  • Rush University, Chicago, IL — PhD — 2024 — Health Sciences

Research Keywords

  • Biomedical Informatics
  • Natural Language Processing
  • Open Science
  • Neurodegenerative Diseases
  • Clinical Trials
  • Biomarkers

Publications

  • Remote outcome measures in Alzheimer’s disease clinical trials: A call to action. J Prev Alzheimers Dis. 2026 Apr; 13(4):100528.. View in PubMed
  • Alzheimer’s clinical research data via R packages: The alzverse. Alzheimers Dement. 2026 Feb; 22(2):e71152.. View in PubMed
  • Towards an AI biomedical scientist: Accelerating discoveries in neurodegenerative disease. J Prev Alzheimers Dis. 2025 Dec 01; 100398.. View in PubMed
  • Financial Incentives to Increase Diversity of Older Participants in a Memory Concerns Registry: A Randomized Clinical Trial. JAMA Health Forum. 2025 Aug 01; 6(8):e252273.. View in PubMed
  • Artificial intelligence-enabled safety monitoring in Alzheimer’s disease clinical trials. J Prev Alzheimers Dis. 2025 Jan; 12(1):100002.. View in PubMed
  • Racial and ethnic differences in plasma biomarker eligibility for a preclinical Alzheimer’s disease trial. Alzheimers Dement. 2024 06; 20(6):3827-3838.. View in PubMed
  • Interpretable discriminant analysis for functional data supported on random nonlinear domains with an application to Alzheimer’s disease. J R Stat Soc Series B Stat Methodol. 2024 Sep; 86(4):1013-1044.. View in PubMed
  • Amyloid and Tau Prediction of Cognitive and Functional Decline in Unimpaired Older Individuals: Longitudinal Data from the A4 and LEARN Studies. J Prev Alzheimers Dis. 2024; 11(4):802-813.. View in PubMed
  • Longitudinal Phospho-tau217 Predicts Amyloid Positron Emission Tomography in Asymptomatic Alzheimer’s Disease. J Prev Alzheimers Dis. 2024; 11(4):823-830.. View in PubMed
  • Maximizing the Utility of Alzheimer’s Disease Trial Data: Sharing of Baseline A4 and LEARN Data. J Prev Alzheimers Dis. 2024; 11(4):889-894.. View in PubMed
  • The AlzMatch Pilot Study – Feasibility of Remote Blood Collection of Plasma Biomarkers for Preclinical Alzheimer’s Disease Trials. J Prev Alzheimers Dis. 2024; 11(5):1435-1444.. View in PubMed
  • Plasma Aβ42/Aβ40 and phospho-tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer’s disease. Alzheimers Dement. 2024 02; 20(2):1214-1224.. View in PubMed
  • Centralizing prescreening data collection to inform data-driven approaches to clinical trial recruitment. Alzheimers Res Ther. 2023 05 02; 15(1):88.. View in PubMed
  • Early-stage Alzheimer disease: getting trial-ready. Nat Rev Neurol. 2022 07; 18(7):389-399.. View in PubMed
  • Corrigendum to: ATRI EDC: a novel cloud-native remote data capture system for large multicenter Alzheimer’s disease and Alzheimer’s disease-related dementias clinical trials. JAMIA Open. 2022 Apr; 5(1):ooac008.. View in PubMed
  • ATRI EDC: a novel cloud-native remote data capture system for large multicenter Alzheimer’s disease and Alzheimer’s disease-related dementias clinical trails. JAMIA Open. 2022 Apr; 5(1):ooab119.. View in PubMed
  • Predicting amyloid risk by machine learning algorithms based on the A4 screen data: Application to the Japanese Trial-Ready Cohort study. Alzheimers Dement (N Y). 2021; 7(1):e12135.. View in PubMed
  • Using Digital Tools to Advance Alzheimer’s Drug Trials During a Pandemic: The EU/US CTAD Task Force. J Prev Alzheimers Dis. 2021; 8(4):513-519.. View in PubMed
  • World-Wide FINGERS Network: A global approach to risk reduction and prevention of dementia. Alzheimers Dement. 2020 07; 16(7):1078-1094.. View in PubMed
  • The Trial-Ready Cohort for Preclinical/Prodromal Alzheimer’s Disease (TRC-PAD) Project: An Overview. J Prev Alzheimers Dis. 2020; 7(4):208-212.. View in PubMed
  • Recruitment into the Alzheimer Prevention Trials (APT) Webstudy for a Trial-Ready Cohort for Preclinical and Prodromal Alzheimer’s Disease (TRC-PAD). J Prev Alzheimers Dis. 2020; 7(4):219-225.. View in PubMed
  • Predicting Amyloid Burden to Accelerate Recruitment of Secondary Prevention Clinical Trials. J Prev Alzheimers Dis. 2020; 7(4):213-218.. View in PubMed
  • TRC-PAD: Accelerating Recruitment of AD Clinical Trials through Innovative Information Technology. J Prev Alzheimers Dis. 2020; 7(4):226-233.. View in PubMed
  • The Trial-Ready Cohort for Preclinical and Prodromal Alzheimer’s Disease (TRC-PAD): Experience from the First 3 Years. J Prev Alzheimers Dis. 2020; 7(4):234-241.. View in PubMed

Similar People